A meta-analysis of 670 patients from observational studies found that CBD-rich whole-plant extracts had higher seizure improvement rates than purified CBD (71% vs 46%), required lower doses (6.0 vs 25.3 mg/kg/day), and caused fewer adverse effects, supporting the entourage effect hypothesis.
Neurologists treating refractory epilepsy; parents choosing between CBD products; cannabis researchers studying the entourage effect.
CBD-rich extracts: 71% improvement at 6 mg/kg/day vs purified CBD: 46% at 25 mg/kg/day
What the researchers found
Researchers pooled data from 11 observational studies involving 670 patients with treatment-resistant epilepsy to compare CBD-rich extracts to purified CBD products.
Overall, 64% of patients (399/622) reported seizure improvement.
CBD-rich extracts were associated with significantly better outcomes:
- 71% improvement rate (318/447) vs 46% for purified CBD (81/175), p < 0.0001.
- Lower average dose needed: 6.0 mg/kg/day vs 25.3 mg/kg/day.
- Fewer mild adverse effects: 33% vs 76%, p < 0.0001.
- Fewer severe adverse effects: 2.2% vs 12.6%, p < 0.0001 (note: rates of severe AEs with purified CBD corrected).
The authors attributed the difference to synergistic effects of CBD with other phytocompounds (the entourage effect), though they noted this needs confirmation in controlled trials.
Why it matters
This is the first systematic comparison of whole-plant CBD extracts versus purified CBD for epilepsy. If the entourage effect is real, it means the pharmaceutical approach of isolating single compounds may sacrifice efficacy. The 4-fold dose difference has practical implications for cost and side effects.
The numbers in context
670 patients, 11 studies. CBD-rich extracts: 71% improvement, 6.0 mg/kg/day mean dose, 33% mild AEs. Purified CBD: 46% improvement, 25.3 mg/kg/day mean dose, 76% mild AEs. Both differences highly significant (p < 0.0001).
How the study worked
Meta-analysis of 11 observational clinical studies. 670 patients with treatment-resistant epilepsy. Fischer test for categorical comparisons. Treatment duration 3-12 months (mean 6.2 months). Doses ranged 1-50 mg/kg/day.
What this study cannot tell us
All observational studies, not randomized trials. Different formulations, doses, and patient populations across studies. Selection bias likely (patients choosing whole-plant may differ from those using purified). Retrospective data quality varies. The entourage effect is proposed but not directly tested.
How to read the evidence
Moderate. Meaningful comparison across multiple studies with large combined sample, but observational design and heterogeneous formulations limit causal conclusions.
When this study was published
Published in 2018. The debate between whole-plant extracts and purified CBD continues, with regulatory frameworks still favoring single-compound products.
The bigger picture
The pharmaceutical model has focused on purified CBD (Epidiolex) because it is easier to study, standardize, and regulate. This meta-analysis suggests that whole-plant extracts may work better at lower doses, raising questions about whether the regulatory preference for single-compound drugs is optimal for cannabis therapeutics.
Questions still open
- Would a head-to-head randomized trial confirm the advantage of whole-plant extracts? Which specific non-CBD compounds contribute to the entourage effect? Can standardized whole-plant extracts be developed for clinical use?
Common questions
What is the entourage effect in this context?
Should patients switch from Epidiolex to whole-plant CBD?
Read the original research
Potential Clinical Benefits of CBD-Rich Cannabis Extracts Over Purified CBD in Treatment-Resistant Epilepsy: Observational Data Meta-analysis.
Frontiers in neurology, 9, 759
Citation
Pamplona, Fabricio A; da Silva, Lorenzo Rolim; Coan, Ana Carolina. (2018). Potential Clinical Benefits of CBD-Rich Cannabis Extracts Over Purified CBD in Treatment-Resistant Epilepsy: Observational Data Meta-analysis.. Frontiers in neurology, 9, 759. https://doi.org/10.3389/fneur.2018.00759
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk